|Strategy:||Combo: DNA & protein vaccines|
|Study Type:||Phase I|
|Stage:||Follow up complete|
|Study Start Date:||2014-07-09|
|Study Made Public:||NA|
A Phase 1b clinical trial to evaluate the safety and immunogenicity of different combinations of DNA-HIV-PT123 and AIDSVAX B/E in healthy, HIV uninfected adult participants
HVTN 105 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of combinations of DNA-HIV-PT123 and AIDSVAX B/E.
Sign in to see full information about this study and to download study data.